First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatm...

by Dean J. Kereiakes, Tim D. Henry, Anthony N. DeMaria, Ohad Bentur, Marilyn Carlson, Corinne Seng Yue, Linda H. Martin, Jeff Midkiff, Michele Mueller, Terah Meek, Deborah Garza, C. Michael Gibson, Barry S. Coller
Published 2020-09-01